Xinnowe (300765.SZ): Subsidiary SYS6043 announced research results at the 2026 American Society of Clinical Oncology Annual Meeting.

Capital Eye Financial News APP, Xin Nuowei (300765.SZ) announced that the company's holding subsidiary, Stone Pharmaceutical Group Jushi Biopharmaceutical Co., Ltd. (referred to as "Jushi Biopharm"), will present the Phase I clinical research data of SYS6043 in oral form at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago from May 29 to June 2, 2026.